AK Steel Holding Corp (NYSE:AKS) will unveil its latest earnings on Tuesday, January 24, 2012. The average estimate of analysts is for a loss of 40 cents per share, a narrower loss from the year earlier quarter net loss of 49 cents. During the past three months, the average estimate has moved down from 4 cents. Between one and three months ago, the average estimate moved down. It also has dropped from a loss of 35 cents during the last month.
The company topped estimates last quarter after missing forecasts the quarter prior. In the third quarter, it reported profit of 2 cents per share against a mean estimate of 0 cents per share. In the second quarter, it missed forecasts by 19 cents. Analysts are projecting a rise of 6.5% in revenue from the year-earlier quarter to $1.48 billion.
Competitors to Watch: Steel Dynamics, Inc. (NASDAQ:STLD), United States Steel Corp. (NYSE:X), Nucor Corporation (NYSE:NUE), Ternium S.A. (NYSE:TX), Commercial Metals Company (NYSE:CMC), Universal Stainless & Alloy Products (NASDAQ:USAP), Allegheny Tech. Inc. (NYSE:ATI), Ampco-Pittsburgh Corp. (NYSE:AP), ArcelorMittal (NYSE:MT), and Schnitzer Steel Industries, Inc. (NASDAQ:SCHN).
Stryker Corp (NYSE:SYK) will unveil its latest earnings on Tuesday, January 24, 2012. The average estimate of analysts is for profit of $1.03 per share, a rise of 10.8% from the company’s actual earnings for the same quarter a year ago. The average estimate is the same as three months ago. Between one and three months ago, the average estimate was unchanged. It also has not changed during the last month. For the year, analysts are projecting net income of $3.73 per share, a rise of 12% from last year.
Last quarter, the company topped estimates by 0 cents, coming in at profit of 91 cents per share against a mean estimate of net income of 89 cents. The company fell in line with estimates in the second quarter. On average, analysts predict $2.22 billion in revenue this quarter, a rise of 11% from the year ago quarter. Analysts are forecasting total revenue of $8.31 billion for the year, a rise of 13.5% from last year’s revenue of $7.32 billion.
Competitors to Watch: Zimmer Holdings, Inc. (NYSE:ZMH), Exactech, Inc. (NASDAQ:EXAC), Smith & Nephew plc (NYSE:SNN), Wright Medical Group, Inc. (NASDAQ:WMGI), Tornier N.V. (NASDAQ:TRNX), CONMED Corporation (NASDAQ:CNMD), ArthroCare Corporation (NASDAQ:ARTC), Medtronic, Inc. (NYSE:MDT), NuVasive, Inc. (NASDAQ:NUVA), and Alphatec Holdings, Inc. (NASDAQ:ATEC).